Summary
A double blind randomised cross over investigation was carried out in 25 male patients undergoing two oral surgical extractions, one for each lower wisdom tooth. The two extractions were performed about 6 weeks apart and were carried out under local anaesthesia. One hour after each extraction the patients randomly received 90 or 45 mg codeine. During the following 5 h the patients rated the intensity of their pain on a visual analogue scale. Blood was simultaneously sampled and assayed for codeine and its metabolite morphine.
Mean pain intensity difference was just significantly higher after 90 mg codeine compared to 45 mg. The mean plasma concentrations of codeine and morphine were significantly higher after the 90 mg dose. However, for the two dose levels of codeine there was no obvious relationship between the difference in analgesic effect and the difference in the plasma concentration of codeine or morphine. The plasma concentrations of morphine were 2–3% of those of codeine and the levels were relatively low. Local formation of morphine from codeine within the human brain should therefore be investigated.
Four patients were unable to demethylate codeine to a detectable plasma concentration of morphine after 90 mg codeine. In those patients the analgesic effect during the first hours was better after 90 mg codeine than after 45 mg.
This suggests some analgesic effect of codeine itself.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Forsgren H, Heimdahl A, Johansson B, Krekmanov L (1985) Effect of application of cold dressings on the postoperative course in oral surgery. Int J Oral Surg 14: 223–228
McQuay HJ, Caroll D, Watts PG, Juniper RP, Moore RA (1989) Codeine 20 mg increases pain relief from ibuprofen 400 mg after third molar surgery. A repeat-dosing comparison of ibuprofen and an ibuprofen-codeine combination. Pain 37: 7–13
Findlay JWA, Butz RF, Welch RM (1977) Codeine kinetics as determined by radioimmunoassay. Clin Pharmacol Ther 22: 439–446
Findlay JWA, Jones EC, Butz RF, Welch RM (1978) Plasma codeine and morphine concentrations after therapeutic oral doses of codeine-containing analgesics. Clin Pharmacol Ther 24: 60–68
Rogers JF, Findlay JWA, Hull JH, Butz RF, Jones EC, Bustrack JA, Welch RM (1982) Codeine disposition in smokers and non-smokers. Clin Pharmacol Ther 32: 218–227
Quiding H, Anderson P, Bondesson U, Boréus LO, Hynning PÅ (1986) Plasma concentrations of codeine and its metabolite, morphine, after single and repeated oral administration. Eur J Clin Pharmacol 30: 673–677
Guay DRP, Awni WM, Halstenson CE, Findlay JWA, Opsahl JA, Abraham PA, Jones EC, Matzke GR (1987) Pharmacokinetics of codeine after single and multiple-oral-dose administration to normal volunteers. J Clin Pharmacol 27: 983–987
Persson K, Hammarlund-Udenaes M, Mortimer Ö, Rane A (1992) The postoperative pharmacokinetics of codeine. Eur J Clin Pharmacol 42: 663–666
Yue QY, Hasselström J, Svensson JO, Säwe J (1991) Pharmacokinetics of codeine and its metabolites in caucasian healthy volunteers: comparisons between extensive and poor hydroxylators of debrisoquine. Br J Clin Pharmacol 31: 635–642
Sanfilippo G (1948) Contributo sperimentale all'ipotesi della smetilazione della codeina nell'organismo. I. Influenze della dose sull'assuefazione alla codeina. II. Assuefazione alla codeina attenuta con somministrazione prolungata di morfina. Boll Soc Ital Biol Sper 24: 723–726
Dayer P, Desmeules J, Leemann T, Striberni R (1988) Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalyzing debrisoquine 4-hydroxylation (cytochrome P-450 dbl/bufI). Biochem Biophys Res Comm 152: 411–416
Chen ZR, Somogyi AA, Bochner F (1988) Polymorphic O-demethylation of codeine. Lancet, II, 914–915
Yue QY, Swensson JO, Alm C, Sjöqvist F, Säwe J (1989) Codeine O-demethylation co-segregates with polymorphic debrisoquine hydroxylation. Br J Clin Pharmacol 28: 639–645
Mortimer Ö, Persson K, Ladona MG, Spalding D, Zanger UM, Meyer UA and Rane A (1990) Polymorphic formation of morphine from codeine in poor and extensive metabolizers of dextromethorphan: relationship to the presence of immunoidentified cytochrome P45OIIDI. Clin Pharmacol Ther 47: 27–35
Jones B, Kenward MG (1989) Design and analysis of cross-over trials. Chapman & Hall, New York
Fleiss JL (1986) The design and analysis of clinical experiments. Wiley & Sons, New York
Shah JC, Mason WD (1990) Plasma codeine and morphine concentrations after single oral dose of codeine phosphate. J Clin Pharmacol 30: 764–766
Quiding H, Olsson GL, Boréus LO, Bondesson U (1992) Infants and young children metabolise codeine to morphine. A study after single and repeated rectal administration. Br J Clin Pharmacol 33: 45–49
Dahlström B, Tamsen A, Paalzow L, Hartvig P (1982) Patient-controlled analgesic therapy: IV. Pharmacokinetics and analgesic plasma concentrations of morphine. Clin Pharmacokinet 7: 266–279
Säwe J, Dahlström B, Rane A (1983) Steady-state kinetics and analgesic effect of oral mophine in cancer patients. Eur J Clin Pharmacol 24: 537–542
Vater M, Smith G, Atherne GW, Aitkenhead AR (1984) Pharmacokinetics and analgesic effect of slow-release oral morphine in cancer patients. Br J Anaesth 56: 821–827
Sindrup SH, Brøsen K, Bjerring P, Arendt-Nielsen L, Larsen U, Angelo H, Gram LF (1991) Codeine increases pain thresholds to copper vapor laser stimuli in extensive but not poor metabolizers of sparteine. Clin Pharmacol Ther 49: 686–694
Chen ZR, Irvine RJ, Bochner F, Somogui AA (1990) Morphine formation from codeine in rat brain: a possible mechanism of codeine analgesia. Life Sci 46: 1067–1074
Osborne R, Joel S, Trew D, Slevin M (1988) Analgesic activity of morphine-6-glucuronide. Lancet I: 828
Hanna MH, Peat SJ, Woodham M, Knibb A, Fung C (1990) Analgesic efficacy and CSF pharmacokinetics of intrathecal morphine-6-glucuronide: comparison with morphine. Br J Anaesth 64: 547–550
Alvan G, Bechtel P, Iselius L, Gundert-Remy U (1990) Hydroxylation polymorphisms of debrisoquine and mephenytion in European populations. Eur J Clin Pharmacol 39: 533–537
Desmeules J, Gascon MP, Dayer P, Magistris M (1991) Impact of environmental and genetic factors on codeine analgesia. Eur J Clin Pharmacol 41: 23–26
Sindrup SH, Arendt-Nielsen L, Brøsen K, Bjerring P, Angelo HR, Eriksen B, Gram LF (1992) The effect of quinidine on the analgesic effect of codeine. Eur J Clin Phrmacol 42: 587–592
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Quiding, H., Lundqvist, G., Boréus, L.O. et al. Analgesic effect and plasma concentrations of codeine and morphine after two dose levels of codeine following oral surgery. Eur J Clin Pharmacol 44, 319–323 (1993). https://doi.org/10.1007/BF00316466
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00316466